No Data
No Data
Telomir Pharmaceuticals | 10-K: FY2024 Annual Report
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Express News | Telomir Pharmaceuticals Inc - Telomir-1 Reverses Copper-Induced Ros Elevation in Human Cell Lines
Express News | Telomir Pharmaceuticals Inc - Announces Breakthrough Results With Telomir-1
Telomir Touts Potential of Telomir-1 in Addressing Oxidative Stress
Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week